- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 318686, 9 pages
Association of Toll-Like Receptor 4 Polymorphisms with Diabetic Foot Ulcers and Application of Artificial Neural Network in DFU Risk Assessment in Type 2 Diabetes Patients
1Department of Molecular & Human Genetics, Banaras Hindu University, Varanasi 221005, India
2Department of Mining Engineering, Indian Institute of Technology, Banaras Hindu University, Varanasi 221005, India
3Department of Endocrinology and Metabolism, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, India
4Department of General Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, India
Received 23 April 2013; Revised 16 June 2013; Accepted 17 June 2013
Academic Editor: Thomas Liehr
Copyright © 2013 Kanhaiya Singh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- International Diabetes Federation, IDF Diabetes Atlas, International Diabetes Federation, Brussels, Belgium, 5th edition, 2011.
- S. Donohue and P. Sutton-Woods, “Lower limb amputation,” in Vascular Disease. Nursing and Management, S. Murray, Ed., Whurr Publishers, London, UK, 2001.
- A. J. Boulton, L. Vileikyte, G. Ragnarson-Tennvall, and J. Apelqvist, “The global burden of diabetic foot disease,” The Lancet, vol. 366, no. 9498, pp. 1719–1724, 2005.
- R. F. Diegelmann and M. C. Evans, “Wound healing: an overview of acute, fibrotic and delayed healing,” Frontiers in Bioscience, vol. 9, pp. 283–289, 2004.
- W. J. Jeffcoate, P. Price, and K. G. Harding, “Wound healing and treatments for people with diabetic foot ulcer,” Diabetes/Metabolism Research and Reviews, vol. 20, no. 1, pp. S78–S89, 2004.
- J. D. Whitney, “Overview: acute and chronic wounds,” Nursing Clinics of North America, vol. 40, no. 2, pp. 191–205, 2005.
- L. Delbridge, G. Ctercteko, and C. Fowler, “The aetiology of diabetic neuropathy ulceration of the foot,” British Journal of Surgery, vol. 72, no. 1, pp. 1–6, 1985.
- G. M. Barton, “A calculated response: control of inflammation by the innate immune system,” Journal of Clinical Investigation, vol. 118, pp. 413–420, 2008.
- O. Joffre, M. A. Nolte, R. Sporri, et al., “Inflammatory signals in dendritic cell activation and the induction of adaptive immunity,” Immunological Reviews, vol. 227, pp. 234–247, 2009.
- L. Chen, S. Guo, M. J. Ranzer, and L. A. DiPietro, “Toll-like receptor 4 has an essential role in early skin wound healing,” Journal of Investigative Dermatology, vol. 133, pp. 258–267, 2013.
- N. Ruzehaji, S. J. Mills, E. Melville, R. Arkell, R. Fitridge, and A. J. Cowin, “The influence of Flightless I on Toll-like-receptor-mediated inflammation in a murine model of diabetic wound healing,” BioMed Research International, vol. 2013, Article ID 389792, 9 pages, 2013.
- A. N. K. Kanhaiya, S. K. Gupta, and K. Singh, “Differential expression of toll like receptor 4 in type 2 diabetic patients with impaired wound healing,” Journal of Diabetes and Metabolism, vol. 4, article 260, 2013.
- N. C. Arbour, E. Lorenz, B. C. Schutte et al., “TLR4 mutations are associated with endotoxin hyporesponsiveness in humans,” Nature Genetics, vol. 25, no. 2, pp. 187–191, 2000.
- L. Apetoh, F. Ghiringhelli, A. Tesniere et al., “Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy,” Nature Medicine, vol. 13, no. 9, pp. 1050–1059, 2007.
- P. Prohinar, P. Rallabhandi, J. P. Weiss, and T. L. Gioannini, “Expression of functional D299G.T399I polymorphic variant of TLR4 depends more on coexpression of MD-2 than does wild-type TLR4,” Journal of Immunology, vol. 184, no. 8, pp. 4362–4367, 2010.
- J. Song, D. Y. Kim, C. S. Kim et al., “The association between Toll-like receptor 4 (TLR4) polymorphisms and the risk of prostate cancer in Korean men,” Cancer Genetics and Cytogenetics, vol. 190, no. 2, pp. 88–92, 2009.
- D. E. Rumelhart, G. E. Hinton, R. J. Williams, et al., “Learning internal representation by error propagation,” in Parallel Distributed Processing, D. E. Rumelhart and J. L. McClelland, Eds., pp. 318–362, MIT Press, Cambridge, Mass, USA, 1986.
- SPSS and IBM, IBM SPSS Statistics For Windows, Version 20. 0, IBM, Armonk, NY, USA, 2011.
- C. Bergmann, H. S. Bachmann, A. Bankfalvi et al., “Toll-like receptor 4 single-nucleotide polymorphisms Asp299Gly and Thr399Ile in head and neck squamous cell carcinomas,” Journal of Translational Medicine, vol. 9, no. 1, pp. 139–147, 2011.
- P. Arora, B. Garcia-Bailo, Z. Dastani et al., “Genetic polymorphisms of innate immunity-related inflammatory pathways and their association with factors related to type 2 diabetes,” BMC Medical Genetics, vol. 12, article 95, 2011.
- M. M. Amoli, S. Hasani-Ranjbar, N. Roohipour et al., “VEGF gene polymorphism association with diabetic foot ulcer,” Diabetes Research and Clinical Practice, vol. 93, no. 2, pp. 215–219, 2011.
- T. H. Mogensen, “Pathogen recognition and inflammatory signaling in innate immune defenses,” Clinical Microbiology Reviews, vol. 22, no. 2, pp. 240–273, 2009.
- M. A. Armant and M. J. Fenton, “Toll-like receptors: a family of pattern-recognition receptors in mammals,” Genome Biology, vol. 3, no. 8, article 3011, 2002.
- S. Akira, S. Uematsu, and O. Takeuchi, “Pathogen recognition and innate immunity,” Cell, vol. 124, no. 4, pp. 783–801, 2006.
- A. M. Krieg and J. Vollmer, “Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity,” Immunological Reviews, vol. 220, no. 1, pp. 251–269, 2007.
- R.-F. Wang, Y. Miyahara, and H. Y. Wang, “Toll-like receptors and immune regulation: implications for cancer therapy,” Oncogene, vol. 27, no. 2, pp. 181–189, 2008.
- G. G. L. Biondi-Zoccai, A. Abbate, G. Liuzzo, and L. M. Biasucci, “Atherothrombosis, inflammation, and diabetes,” Journal of the American College of Cardiology, vol. 41, no. 7, pp. 1071–1077, 2003.
- S. Gallucci and P. Matzinger, “Danger signals: SOS to the immune system,” Current Opinion in Immunology, vol. 13, no. 1, pp. 114–119, 2001.
- K. Hoshino, O. Takeuchi, T. Kawai et al., “Cutting edge: toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide evidence for TLR4 as the Lps gene product,” Journal of Immunology, vol. 162, no. 7, pp. 3749–3752, 1999.
- B. Gao and M.-F. Tsan, “Endotoxin contamination in recombinant human heat shock protein 70 (Hsp70) preparation is responsible for the induction of tumor necrosis factor α release by murine macrophages,” Journal of Biological Chemistry, vol. 278, no. 1, pp. 174–179, 2003.
- M. R. Dasu, S. Devaraj, S. Park, and I. Jialal, “Increased Toll-Like Receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects,” Diabetes Care, vol. 33, no. 4, pp. 861–868, 2010.
- J. A. Nogueira-Machado, C. M. D. O. Volpe, C. A. Veloso, and M. M. Chaves, “HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation,” Expert Opinion on Therapeutic Targets, vol. 15, no. 8, pp. 1023–1035, 2011.
- S. Brand, T. Staudinger, F. Schnitzler et al., “The role of Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn's disease,” Inflammatory Bowel Diseases, vol. 11, no. 7, pp. 645–652, 2005.
- G. L. Hold, C. S. Rabkin, W.-H. Chow et al., “A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors,” Gastroenterology, vol. 132, no. 3, pp. 905–912, 2007.
- B. R. Achyut, U. C. Ghoshal, N. Moorchung, and B. Mittal, “Association of Toll-like receptor-4 (Asp299Gly and Thr399Ileu) gene polymorphisms with gastritis and precancerous lesions,” Human Immunology, vol. 68, no. 11, pp. 901–907, 2007.
- L. Henckaerts, K. R. Nielsen, and R. Steffensen, “Polymorphisms in innate immunity genes predispose to bacteremia and death in the medical intensive care unit,” Critical Care Medicine, vol. 37, pp. 192–201, 2009.
- S. E. Budulac, H. M. Boezen, P. S. Hiemstra, et al., “Toll-like receptor (TLR2 and TLR4) polymorphisms and chronic obstructive pulmonary disease,” PLoS ONE, vol. 7, no. 8, Article ID e43124, 2012.
- K. G. E. Miedema, E. M. Te Poele, W. J. E. Tissing et al., “Association of polymorphisms in the TLR4 gene with the risk of developing neutropenia in children with leukemia,” Leukemia, vol. 25, no. 6, pp. 995–1000, 2011.
- G. Rudofsky Jr., P. Reismann, S. Witte et al., “Asp299Gly and Thr399Ile genotypes of the TLR4 gene are associated with a reduced prevalence of diabetic neuropathy in patients with type 2 diabetes,” Diabetes Care, vol. 27, no. 1, pp. 179–183, 2004.